EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

Improved Glucagon Sensitivity Following Weight Loss: A Systematic Review and Meta‐Analysis

Hye-Rin Charlotte Kim iD, Lima Hamidi, Anne Majumdar, Matyas Fehervari, Emma Rose McGlone iD

Obesity Reviews · 2026-12 · 27 (12)

DOI: 10.1111/obr.70167 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Obesity Reviews, online erschienen am 18.05.2026. Verfasst von Hye-Rin Charlotte Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Glucagon, Weight Loss, Obesity, Alanine. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This systematic review and meta‐analysis investigated the effect of weight loss in people with obesity on two biomarkers of glucagon resistance: fasting plasma glucagon and alanine.

Methods

A comprehensive search was conducted in Medline and Embase. Random‐effects meta‐analyses and correlation analyses were performed. Risk of bias was assessed using the Cochrane RoB 2 and MINORS tools.

Results

Forty‐seven studies comprising 69 interventions and 2061 participants were included. Pooled mean weight loss was −18.23 kg (95% CI [−20.20, −16.27]). Both fasting glucagon and alanine decreased following weight loss: −4.05 pmol/L (95% CI [−4.50, −3.60]; p < 0.001) and −17.9% (95% CI [−22.7, −13.1]; p < 0.0001), respectively. Glucagon reduction occurred with all weight‐loss intervention types: surgical −3.85 pmol/L (95% CI [−5.48, −2.22]; p < 0.0001), dietary −2.87 pmol/L (95% CI [−4.20, −1.54]; p < 0.0001), and pharmacological −5.32 pmol/L (95% CI [−9.85, −0.78]; p < 0.0001). Greater weight loss correlated with larger reductions in fasting glucagon (Pearson r = 0.3255, p = 0.0064). Heterogeneity was high, and overall risk of bias was moderate.

Conclusions

Weight loss is associated with significant reductions in fasting glucagon and alanine concentrations, suggesting improved hepatic glucagon sensitivity and partial restoration of the liver–α‐cell axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonWeight LossObesityAlanineHumansBiomarkersFasting

Stichwörter der Autor:innen

bariatric surgeryglucagonobesityweight loss

Substanzen

GlucagonAlanineBiomarkers

Autor:innen und Institutionen

  • Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • London North West University Healthcare NHS Trust, London, UK.
  • Department of Health Studies, Royal Holloway University of London, Egham, UK.
  • Department of Surgery and Cancer, Imperial College London, London, UK.
  • Department of Bariatric Surgery, Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, UK.
  • Department of Bariatric Surgery, Whittington Hospital NHS Trust, London, UK.

ORCID-Profile: Hye-Rin Charlotte Kim, Emma Rose McGlone

Förderung

  • NIHR

Zitieren

APA

Kim, H. C., Hamidi, L., Majumdar, A., Fehervari, M., & McGlone, E. R. (2026). Improved Glucagon Sensitivity Following Weight Loss: A Systematic Review and Meta‐Analysis. Obesity Reviews, 27(12). https://doi.org/10.1111/obr.70167

Vancouver

Kim HC, Hamidi L, Majumdar A, Fehervari M, McGlone ER. Improved Glucagon Sensitivity Following Weight Loss: A Systematic Review and Meta‐Analysis. Obesity Reviews. 2026;27(12). doi:10.1111/obr.70167

BibTeX
@article{Kim2026,
  author = {Kim, Hye-Rin Charlotte and Hamidi, Lima and Majumdar, Anne and Fehervari, Matyas and McGlone, Emma Rose},
  title = {Improved Glucagon Sensitivity Following Weight Loss: A Systematic Review and Meta‐Analysis},
  journal = {Obesity Reviews},
  year = {2026},
  volume = {27},
  number = {12},
  doi = {10.1111/obr.70167}
}
Kostenlos starten →